The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multi-site randomized trial of a collaborative palliative and oncology care model for patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) receiving non-intensive therapy.
 
Areej El-Jawahri
Stock and Other Ownership Interests - Tuesday Health
Consulting or Advisory Role - AIM Specialty Health; GlaxoSmithKline; Incyte; Novartis
Research Funding - Blue Note Therapeutics
 
Alison Kavanaugh
No Relationships to Disclose
 
Joseph A. Greer
Consulting or Advisory Role - BeiGene
Research Funding - Blue Note Therapeutics (Inst); NCCN/AstraZeneca (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Oxford University Press; Royalties from Springer Publishing Company for edited book, "The Massachusetts General Hospital Handbook of Behavioral Medicine."
 
Vicki Jackson
Consulting or Advisory Role - Tuesday Health
Patents, Royalties, Other Intellectual Property - I am an inventor on a digital health tool used by Tuesday Health
 
Jillian Gustin
No Relationships to Disclose
 
Alice S. Mims
No Relationships to Disclose
 
Albert Cook
No Relationships to Disclose
 
Thomas William LeBlanc
Stock and Other Ownership Interests - Dosentrx; Thyme Care
Honoraria - Genentech; Lilly
Consulting or Advisory Role - Abbvie/Genentech; Agios/Servier; Apellis Pharmaceuticals; Astellas Pharma; BeiGene; Blue Note Therapeutics; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Novartis; Pfizer
Speakers' Bureau - Abbvie; Bristol-Myers Squibb/Celgene; Incyte; Rigel; SERVIER
Research Funding - Bristol Myers Squibb (Inst); Jazz Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate Inc., royalty
Travel, Accommodations, Expenses - Abbvie/Genentech; Bristol-Myers Squibb/Celgene; Incyte; Rigel; SERVIER
 
Joanna Choe
No Relationships to Disclose
 
Mathew Reynolds
No Relationships to Disclose
 
Amir Tahmasb Fathi
Consulting or Advisory Role - Abbvie; Agios; Amgen; Astellas Pharma; Autolus; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; EnClear Therapies; FORMA Therapeutics; Genentech; Immunogen; Ipsen; Kite, a Gilead company; Mablytics; MorphoSys; Novartis; Orum Therapeutics; Pfizer; PureTech; Rigel; SERVIER; Takeda
Research Funding - Abbvie (Inst); agios (Inst); Bristol-Myers Squibb (Inst); SERVIER (Inst)
 
Gabriela Hobbs
Employment - Regeneron (I); Regeneron (I)
Stock and Other Ownership Interests - Regeneron (I)
Consulting or Advisory Role - Abbvie; Blueprint Medicines; GlaxoSmithKline; Incyte; Keros Therapeutics; Novartis; Pfizer; Pharmaxis; Protagonist Therapeutics
Research Funding - Incyte
 
Andrew Mark Brunner
No Relationships to Disclose
 
Jennifer S. Temel
No Relationships to Disclose